Life science translation is the specialized translation of clinical, pharmaceutical, biotechnology, medical-device and healthcare content. It combines scientific expertise, controlled terminology, market-specific requirements and documented quality review. The right workflow depends on the document’s purpose, audience and risk—not simply its word count or language pair.
Updated: October 6, 2026
What Is Life Science Translation?
Life science translation covers content created throughout the development, approval, manufacture, distribution and safe use of medicines, medical devices, diagnostics and biotechnology products. Typical users include pharmaceutical and biotech companies, medical-device manufacturers, contract research organizations (CROs), laboratories, healthcare providers and regulatory teams.
Unlike general translation, the target text may guide a patient’s consent, support a regulatory submission, describe an adverse event or explain how to operate a device. Fluency alone is not enough: the translation must preserve the source meaning, use approved terminology, fit the intended reader and follow the applicable market process.
Life Science Translation vs. Medical Translation
Medical translation is often used for patient care, clinical records and healthcare communication. Life science translation is broader: it also covers pharmaceutical development, clinical research, biotechnology, regulatory submissions, medical devices, pharmacovigilance and scientific publications. The terms overlap, but a buyer should specify the exact document type and use case.
| Content area | Common documents | Primary readers |
|---|---|---|
| Clinical research | Protocols, investigator brochures, informed consent forms, case report forms and recruitment materials | Investigators, ethics committees and trial participants |
| Regulatory affairs | Submission modules, authority correspondence, product information and labeling | Regulators and regulatory teams |
| Pharmaceutical safety | Adverse-event narratives, safety reports and risk-management materials | Safety teams, regulators and clinicians |
| Medical devices and IVDs | Instructions for use, labels, user interfaces, manuals and training | Healthcare professionals, technicians and patients |
| Clinical outcome assessments | Patient-, clinician- and observer-reported instruments and eCOA content | Trial participants, sites and research teams |
| Scientific and commercial | Research papers, posters, websites, e-learning and product education | Scientists, healthcare professionals and customers |
Why Is Life Science Translation High Risk?
- Patient understanding: consent and patient-facing information must be clear for the intended population.
- Clinical meaning: dosage, eligibility, endpoint or safety language cannot be weakened or changed.
- Regulatory acceptance: authorities may require particular languages, templates, terminology and submission formats.
- Data integrity: poorly adapted questionnaires can change how participants understand and answer an item.
- Version control: one source change may need to be traced across many languages and deliverables.
- Confidentiality: clinical and patient content may contain sensitive or commercially restricted information.
The ICH Good Clinical Practice guidance, for example, states that informed-consent information and translations should be relevant, clear, concise and understandable to the participant. Requirements still vary by product, document, country and authority, so the translation brief should identify the governing pathway before work starts.
The Life Science Translation Process
- Define the use and risk. Record the product, document type, intended reader, submission context, countries, languages and consequences of error.
- Prepare the source. Resolve ambiguity, lock the approved version and collect reference files, templates and previous authority-approved text.
- Build terminology controls. Create an approved glossary, abbreviation list and style guide using recognized resources and client terminology.
- Assign qualified specialists. Match translators and reviewers to the therapeutic area, document type, language and market.
- Translate in a controlled environment. Protect tags, numbers, units, product names and repeated content while maintaining traceability.
- Perform independent revision. A second qualified linguist compares the complete target text with the source for meaning, terminology and completeness.
- Add the required validation. Depending on the use, this may include clinician review, back translation, reconciliation, cognitive debriefing or authority review.
- Run final QA and deliver records. Check formatting, labels, tables, numbers, links, locale conventions and final files; archive approvals and change history.
Quality Controls That Matter
| Control | What it checks | When it is useful |
|---|---|---|
| Bilingual revision | Meaning, omissions, additions, terminology and accuracy against the source | Core control for high-risk translated content |
| Subject-matter review | Scientific and clinical suitability in context | Specialized or technically complex content |
| Back translation | Conceptual differences revealed by translating the target back into the source language | Selected research instruments or sponsor-defined validation workflows |
| Reconciliation | Differences among source, forward translation and back translation | Linguistic validation projects |
| Cognitive debriefing | Whether representatives of the target population understand an instrument as intended | Patient-reported outcomes and selected patient-facing measures |
| Automated QA | Numbers, units, missing text, terminology, punctuation and formatting patterns | Every project as a supplement to human review |
| In-context review | Layout, truncation, user interface behavior and final-document usability | Device software, eCOA, websites, labels and formatted deliverables |
Back translation is not automatically necessary for every life science document. It answers a specific comparison question and can add cost without improving every use case. The validation plan should be chosen according to risk, sponsor procedure, instrument requirements and regulator expectations.
Specialized Life Science Translation Workflows
Clinical Trial and Informed Consent Translation
Clinical programs may require protocols, consent forms, site documents, recruitment materials, labels and outcome measures in multiple languages. Investigator-facing content must retain technical precision; participant-facing content must also support comprehension and health literacy. Teams should plan translations early enough for ethics and authority questions, amendments and synchronized country submissions.
Regulatory and Pharmaceutical Translation
Product information, labels and submission content often follow prescribed templates and review processes. The European Medicines Agency’s linguistic-review resources illustrate how translation quality, terminology, template conventions and delivery timing become part of the authorization workflow.
Safety content also depends on controlled terminology. MedDRA is the standardized multilingual medical terminology developed by ICH for regulatory information and safety monitoring; its numeric codes remain consistent across language versions.
Medical Device and IVD Translation
Device projects may include instructions for use, labels, packaging, software strings, user interfaces, service manuals and training. Required languages can differ by market and user group. The European Commission publishes country-level MDR and IVDR language tables, including information about interfaces. Manufacturers should confirm the current requirements for every destination market instead of relying on a single EU-wide assumption.
Clinical Outcome Assessment and Linguistic Validation
Patient-reported and other clinical outcome assessments require conceptual equivalence, not merely natural wording. A full workflow may include translatability review, dual forward translation, reconciliation, back translation, developer review, cognitive debriefing, proofreading and electronic migration testing. The exact steps depend on the instrument owner, study plan and intended regulatory use.
Can AI or Machine Translation Be Used?
Technology can accelerate terminology checks, repeated-content handling and lower-risk content, but it does not remove accountability. Raw machine output can introduce fluent but clinically wrong wording, omit negation or mishandle a protected term. It can also create confidentiality concerns if content is sent to an unapproved system.
Use a documented, risk-based policy: classify the content, approve the technology environment, restrict sensitive data, define human checkpoints and validate the final output for its intended use. Note that the published scope of ISO 17100 covers core translation-service processes and resources but excludes raw machine-translation output plus post-editing.
How to Choose a Life Science Translation Provider
- Ask for experience with your exact document type, therapeutic area and target markets.
- Confirm how linguists and independent reviewers are qualified and assigned.
- Review the provider’s quality-management process, certifications and audit readiness.
- Require documented terminology, version control, approvals and corrective-action handling.
- Check information-security controls, data location, access permissions and AI-use policy.
- Confirm capacity for urgent safety content, simultaneous submissions and amendment cycles.
- Request a realistic validation and in-context testing plan rather than a generic “medical review.”
AsiaLocalize provides life sciences translation services and medical translation services for multilingual clinical, pharmaceutical, device and patient-facing content.
Common Life Science Translation Mistakes
- Starting translation before the source version and references are approved.
- Using one generic medical glossary for every product and market.
- Applying back translation as a ritual without defining what it should validate.
- Letting one person translate and approve their own high-risk work.
- Ignoring tables, figures, screenshots, labels and software strings outside the main text.
- Skipping final-layout or in-context review after the bilingual text is approved.
- Assuming certification alone proves suitability for a specific regulated workflow.
Build a Defensible Multilingual Workflow
Reliable life science translation begins with intended use. When the document, audience, market and risk are clear, teams can choose the right experts, terminology controls, review layers and validation evidence. That produces content that is not only readable, but also traceable and fit for its clinical or regulatory purpose.
Frequently Asked Questions
What is life science translation?
Life science translation is the specialized translation of clinical, pharmaceutical, biotechnology, medical-device, regulatory and healthcare content for specific markets and audiences.
What documents require life science translation?
Common documents include clinical trial protocols, informed consent forms, regulatory submissions, adverse-event reports, product information, medical-device instructions, labels, software strings and clinical outcome assessments.
How is life science translation quality checked?
Quality controls may include terminology management, translation by a qualified specialist, independent bilingual revision, subject-matter review, automated QA, formatting checks and final in-context review. Some uses require additional linguistic validation.
Is back translation always required?
No. Back translation is useful in selected linguistic-validation or sponsor-defined workflows, but it is not automatically required for every document. The validation plan should match the content’s purpose, risk and applicable requirements.
Can machine translation be used for life science content?
It may be appropriate for selected content within an approved, secure and risk-based workflow. High-risk output still needs qualified human review, terminology control and validation for its intended use.
What should you look for in a life science translation provider?
Look for document-specific and therapeutic-area expertise, qualified reviewers, a documented quality system, terminology and version controls, information security, regulatory-market knowledge and auditable project records.
